PharmaCorp Rx specializes in seamless pharmacy ownership transitions with legacy preservation and financial security.
PharmaCorp Rx has raised $14.2M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in November 2025.
PharmaCorp Rx's investors include CIBC.
PharmaCorp Rx is headquartered in Saskatoon, Canada.
PharmaCorp Rx specializes in seamless pharmacy ownership transitions with legacy preservation and financial security.
PharmaCorp Rx is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"PharmaCorp Rx — Funding & Investors." VCBacked, November 5, 2025, https://www.vcbacked.co/company/pharmacorp-rx. Accessed September 30, 2026.
VCBacked. (2025). PharmaCorp Rx — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/pharmacorp-rx
{{cite web |title=PharmaCorp Rx — Funding & Investors |url=https://www.vcbacked.co/company/pharmacorp-rx |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated